PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026Cancer Research0 citations

Abstract 4373: Rational design of immune-cell-homing macroporous hydrogels for enhanced dendritic cell recruitment and cancer vaccination

View Full Paper
WXWenhao XuHWHua Wang

Key Points

  • This research aims to optimize macroporous hydrogels for improved dendritic cell recruitment and better vaccine efficacy.
  • Engineered an alginate-based macroporous hydrogel with independently tunable properties.
  • Systematically investigated the effects of stiffness, viscosity, and pore size on dendritic cell recruitment.
  • Employed formulations with GM-CSF, OVA, and CpG for evaluating T-cell responses.
  • High stiffness, viscosity, and large pores increased dendritic cell recruitment by 1.6-fold.
  • Hydrogels supported deeper cellular infiltration and elevated MHC II expression.
  • Optimized hydrogel formulations led to significant CD8+ T-cell expansion and delayed tumor progression in a prophylactic model.

Abstract

Abstract Macroporous biomaterials have emerged as a promising platform for in situ cancer vaccination because they can create localized immune niches that recruit, activate, and program dendritic cells (DCs) more effectively than traditional soluble vaccines. However, the immune-cell homing profile of these materials remains difficult to rationally control because key physical parameters—stiffness, viscosity, and pore size—are often inherently coupled. To overcome this challenge, we engineered an alginate-based macroporous hydrogel in which these properties were independently tunable, enabling a systematic investigation of how each dimension shapes DC recruitment and downstream antitumor immunity. The resulting design space revealed a striking synergy: hydrogels combining high stiffness, high viscosity, and large interconnected pores generated the most favorable immune microenvironment, recruiting 1.6-fold more DCs and markedly enriching the cDC1 subset associated with efficient cross-presentation. Large-pore hydrogels supported deeper cellular infiltration and increased MHC II expression, while high-viscosity formulations enhanced cell retention within the scaffold. Although softer matrices facilitated early migration in vitro, stiffer gels promoted superior DC proliferation, survival, and release, revealing a two-phase mechanism in which initial recruitment and sustained persistence are governed by distinct material properties. When loaded with GM-CSF, OVA, and CpG, the optimized hydrogel induced the strongest SIINFEKL-specific CD8+ T-cell expansion and achieved significantly delayed tumor progression in prophylactic E.G7-OVA challenge, outperforming all other formulations and soluble controls. These findings establish a mechanistic framework for engineering macroporous hydrogels as programmable immune niches and demonstrate that precise decoupling of material mechanics and pore architecture can amplify vaccine potency in vivo. This work advances the rational design of biomaterial-based cancer vaccines and highlights the importance of material-immune cell crosstalk in generating durable antitumor immunity. AI-assisted text generation (ChatGPT) was used solely for language refinement of this abstract. Citation Format: Wenhao Xu, Hua Wang. Rational design of immune-cell-homing macroporous hydrogels for enhanced dendritic cell recruitment and cancer vaccination abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 4373.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Xu et al. (2026) studied this question.

synapsesocial.com/papers/69d1fceba79560c99a0a2a05https://doi.org/10.1158/1538-7445.am2026-4373
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Stimuli-Responsive Hydrogel Platforms for Cancer Immunotherapy: Advances in Design, Mechanisms, and Clinical Translation2026
  2. 2Abstract 6713: Engineering a hydrogel-based vaccine to prevent recurrence in pancreatic ductal adenocarcinoma2026
  3. 3Abstract 6745: Crafting hyaluronic acid-based nanoparticles for enhanced LN targeting as a potent priming tool in immunotherapy2024
  4. 4Abstract 3735: Combinatorial targeting of tumor-microenvironment together with antigen vaccination using innovative nano-immuno-gel for enhanced cancer-immunotherapy2024
  5. 5Abstract 4091: A novel cancer vaccine based on hyaluronic acid nanogel combined with adoptive T cell therapy induces complete regression of established tumors and long-lasting memory CD8+ T cells2024